During public heath emergencies - like the COVID-19 pandemic - when no known preventive or effective treatment exists, researchers want to quickly start conducting studies with humans to find a vaccine and therapeutic treatments that are safe and effective, prompting experts to warn about the importance of maintaining ethical standards.

Rutgers School of Public Health associate professor, Michael K. Gusmano, PhD, is available to discuss the ethics behind developing COVID-19 treatment and vaccination.  

“In the rush to find a COVID-19 vaccine and one or more drugs to treat the deadly disease, concerns are being raised that ethical standards for conducting human clinical trials, and the evidentiary standards for determining whether interventions are safe and effective, might be loosened too much,” said Gusmano, who is also a Hastings Center Scholar.  



The Rutgers School of Public Health is New Jersey’s leading academic institution in public health that is committed to advancing health and wellbeing and preventing disease throughout New Jersey, the United States, and the world, by preparing students as public health leaders, scholars, and practitioners; conducting public health research and scholarship; engaging collaboratively with communities and populations; and actively advocating for policies, programs, and services through the lens of equity and social justice. Learn how the Rutgers School of Public Health is "keeping the ‘public’ in public health,” by visiting them at https://sph.rutgers.edu.